 Percutaneous Angioplasty of the
Carotid Artery versus Endarterectomy (SPACE) trial was
designed to test “equivalence” between CEA and CAS in

e18 Ricotta et al

patients with neurologic symptoms. This trial stopped after
recruitment of 1200 patients due to the futility of proving
equivalence between the two treatments. The rate of death
or ipsilateral stroke at 30 days was 